Literature DB >> 19366855

The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.

Manuela Vargiolu1, Daniela Fusco, Ivana Kurelac, Dietmar Dirnberger, Ralf Baumeister, Isabella Morra, Antonio Melcarne, Roberto Rimondini, Giovanni Romeo, Elena Bonora.   

Abstract

CONTEXT: RET is a tyrosine kinase transmembrane receptor expressed in two main alternative isoforms: RET9 and RET51. RET transduces a positive signal leading to survival, differentiation, or migration in the presence of its ligand glial cell line-derived neurotrophic factor, whereas in its absence a proapoptotic fragment that initiates a negative signaling for apoptosis is generated. The signal transduction mechanisms leading to apoptosis are still unclear.
OBJECTIVE: To shed light on the mechanisms of RET-induced apoptosis, we searched for novel interactors of RET51.
DESIGN: The "split ubiquitin yeast two-hybrid system" was used with RET51 as bait against a human brain expression library.
RESULTS: We identified aryl hydrocarbon receptor-interacting protein (AIP), a cochaperone recently found mutated in pituitary adenoma patients, as a novel interactor of RET. We showed that RET interacts specifically with AIP both in mammalian cell lines and in vivo in the pituitary gland, regardless of the presence of pituitary adenoma-specific mutations. AIP and RET genes were sequenced in 28 pituitary adenoma, but no relevant mutations were found. In addition, we identified the proapoptotic domain of RET as responsible for the interaction with AIP. Finally, we demonstrated that the AIP-RET interaction does not require RET kinase activity or kinase-dependent signal transduction and that it prevents the formation of the AIP-survivin complex.
CONCLUSIONS: The identification of the AIP-RET complex represents a starting point to study key cellular processes involved in RET-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19366855     DOI: 10.1210/jc.2008-1980

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

Review 1.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?

Authors:  G Occhi; M L Jaffrain-Rea; G Trivellin; N Albiger; F Ceccato; E De Menis; M Angelini; S Ferasin; A Beckers; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-03-30       Impact factor: 4.256

3.  The aryl hydrocarbon receptor (AHR) transcription factor regulates megakaryocytic polyploidization.

Authors:  Stephan Lindsey; Eleftherios T Papoutsakis
Journal:  Br J Haematol       Date:  2011-01-12       Impact factor: 6.998

Review 4.  The evolving role of the aryl hydrocarbon receptor (AHR) in the normophysiology of hematopoiesis.

Authors:  Stephan Lindsey; Eleftherios T Papoutsakis
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

Review 5.  Familial isolated pituitary adenomas: from genetics to therapy.

Authors:  Federica Guaraldi; Roberto Salvatori
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

6.  Cushing Disease in a patient with Multiple Endocrine Neoplasia type 2B.

Authors:  Kannan Kasturi; Lucas Fernandes; Martha Quezado; Mary Eid; Leigh Marcus; Prashant Chittiboina; Mark Rappaport; Constantine A Stratakis; Brigitte Widemann; Maya Lodish
Journal:  J Clin Transl Endocrinol Case Rep       Date:  2017-06

7.  A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.

Authors:  C Urbani; D Russo; F Raggi; M Lombardi; C Sardella; I Scattina; I Lupi; L Manetti; L Tomisti; C Marcocci; E Martino; F Bogazzi
Journal:  J Endocrinol Invest       Date:  2014-07-05       Impact factor: 4.256

Review 8.  Familial isolated pituitary adenomas: an emerging clinical entity.

Authors:  F Martucci; G Trivellin; M Korbonits
Journal:  J Endocrinol Invest       Date:  2012-12       Impact factor: 4.256

Review 9.  The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.

Authors:  Catrin Lloyd; Ashley Grossman
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

Review 10.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.